Bacteriemia secundaria a pancolitis por Campylobacter jejuni en un paciente inmunocompetente.

Saved in:
Bibliographic Details
Title: Bacteriemia secundaria a pancolitis por Campylobacter jejuni en un paciente inmunocompetente.
Alternate Title: Bacteremia secondary to Campylobacter jejuni pancolitis in an immunocompetent patient.
Authors: Sejas-Claros, Alfredo1 al-sejas@hotmail.com, Cano-Pérez, Marta1, Francisca Sánchez-Borge, Belén1, Lorenzo-Vidal, Belén1, María Eiros-Bouza, José1
Source: Revista Española de Quimioterapia. abr2026, Vol. 39 Issue 2, p160-162. 3p.
Subjects: BACTEREMIA, CAMPYLOBACTER jejuni, AZITHROMYCIN, MICROORGANISMS, COLITIS, DRUG resistance in bacteria, IMMUNOCOMPROMISED patients
Abstract (English): The article focuses on a clinical case of bacteremia secondary to pancolitis caused by Campylobacter jejuni in a young immunocompetent patient, a rare situation since this invasive infection usually affects mainly immunocompromised individuals or those with comorbidities. The favorable clinical course of the patient is described following initial empirical antibiotic treatment, despite the microorganism showing resistance to ciprofloxacin, and the subsequent administration of azithromycin. The literature review indicates that, in young patients without underlying diseases, bacteremia caused by C. jejuni can be transient and resolve spontaneously, possibly due to an effective immune response, whereas in immunocompromised patients it can be severe. Additionally, the microbiological characteristics of the pathogen and current recommendations on antimicrobial management based on the microorganism’s susceptibility are discussed. [Extracted from the article]
Abstract (Spanish): El artículo se centra en un caso clínico de bacteriemia secundaria a pancolitis causada por Campylobacter jejuni en un paciente joven inmunocompetente, situación poco frecuente ya que esta infección invasiva suele afectar principalmente a personas inmunodeprimidas o con comorbilidades. Se describe la evolución clínica favorable del paciente tras tratamiento antibiótico empírico inicial, a pesar de que el microorganismo mostró resistencia a ciprofloxacino, y la posterior administración de azitromicina. La revisión bibliográfica señala que, en pacientes jóvenes sin enfermedades subyacentes, la bacteriemia por C. jejuni puede ser transitoria y resolverse espontáneamente, posiblemente debido a una respuesta inmunitaria eficaz, mientras que en pacientes inmunodeprimidos puede ser grave. Además, se discuten las características microbiológicas del patógeno y las recomendaciones actuales sobre el manejo antimicrobiano basadas en la sensibilidad del microorganismo. [Extracted from the article]
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:The article focuses on a clinical case of bacteremia secondary to pancolitis caused by Campylobacter jejuni in a young immunocompetent patient, a rare situation since this invasive infection usually affects mainly immunocompromised individuals or those with comorbidities. The favorable clinical course of the patient is described following initial empirical antibiotic treatment, despite the microorganism showing resistance to ciprofloxacin, and the subsequent administration of azithromycin. The literature review indicates that, in young patients without underlying diseases, bacteremia caused by C. jejuni can be transient and resolve spontaneously, possibly due to an effective immune response, whereas in immunocompromised patients it can be severe. Additionally, the microbiological characteristics of the pathogen and current recommendations on antimicrobial management based on the microorganism’s susceptibility are discussed. [Extracted from the article]
ISSN:02143429
DOI:10.37201/req/135.2025